Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The AURORA Study is evaluating the safety, tolerability, and efficacy of an investigational mRNA CAR T-cell therapy known as Descartes-08 in adults with acetylcholine receptor autoantibody -positive generalized myasthenia gravis. Part 1 of the study will last around 6 months. For eligible participants, Part 2 will last around 8 months.
Epistemonikos ID: d975cf2ea59e747b1186afb907aa3a76dabf3eb0
First added on: Feb 01, 2025